找回密码
 To register

QQ登录

只需一步,快速开始

扫一扫,访问微社区

SCIE期刊CARDIOVASCULAR DRUGS AND THERAPY 2024/2025影响因子:3.146 (CARDIOVASC DRUG THER) (0920-3206). (CARDIAC & CARDIOVASCULA

[复制链接]
楼主: Flexibility
发表于 2025-3-26 23:15:35 | 显示全部楼层
Submitted on: 10 September 2022. Revised on: 06 December 2022. Accepted on: 17 December 2022. ___________________CARDIOVASCULAR DRUGS AND THERAPY
发表于 2025-3-27 04:58:11 | 显示全部楼层
Submitted on: 10 February 2025. Revised on: 27 May 2025. Accepted on: 21 June 2025. ___________________CARDIOVASCULAR DRUGS AND THERAPY
发表于 2025-3-27 09:04:49 | 显示全部楼层
Submitted on: 02 November 2015. Revised on: 01 January 2016. Accepted on: 02 February 2016. ___________________CARDIOVASCULAR DRUGS AND THERAPY
发表于 2025-3-27 10:06:07 | 显示全部楼层
Submitted on: 31 May 2001. Revised on: 19 July 2001. Accepted on: 11 August 2001. ___________________CARDIOVASCULAR DRUGS AND THERAPY
发表于 2025-3-27 13:59:51 | 显示全部楼层
Submitted on: 20 August 2014. Revised on: 21 November 2014. Accepted on: 24 December 2014. ___________________CARDIOVASCULAR DRUGS AND THERAPY
发表于 2025-3-27 18:52:16 | 显示全部楼层
Submitted on: 05 January 2007. Revised on: 28 March 2007. Accepted on: 14 May 2007. ___________________CARDIOVASCULAR DRUGS AND THERAPY
 关于派博传思  派博传思旗下网站  友情链接
派博传思介绍 公司地理位置 论文服务流程 影响因子官网 SITEMAP 大讲堂 北京大学 Oxford Uni. Harvard Uni.
发展历史沿革 期刊点评 投稿经验总结 SCIENCEGARD IMPACTFACTOR 派博系数 清华大学 Yale Uni. Stanford Uni.
|Archiver|手机版|小黑屋| 派博传思国际 ( 京公网安备110108008328) GMT+8, 2025-4-26 23:22
Copyright © 2001-2015 派博传思   京公网安备110108008328 版权所有 All rights reserved
快速回复 返回顶部 返回列表